Hollywood, FL, Aug. 22, 2017 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC PINK: ETST) (“ETST” or “the Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, and medical device research and development, announces a strategic partnership with the new Canadian division of Brazil’s Bionatus Pharmaceutical Laboratory.The two companies will initially cooperate to improve two of Bionatus’ existing products that have been successful in the Brazilian market, and then launch them in the USA. Both products are in liquid form. Propovit is a spray with ingredients derived from honey. It is used to refresh the mouth and relieve sore throat symptoms.Dr. Michel Aube, ETST’s CEO & CSO updates with, “we have selected the research center that will conduct the in vitro assays to demonstrate the efficiency of the nutraceuticals in the ETST product pipeline which are based on the company’s International Provisory Patent Application. As recently announced, we will soon deliver the formulas to the Centre De Développement Bioalimentaire Du Québec Inc., (CDBQ) for mass formula conversion. Thereafter, the new partner that will test the products’ biological activity will be announced. We are also finalizing the logistics of the launch of the much-awaited MSN-2 medical device with its partner, Michel Gauthier, MD. That are on schedule for the anticipated Q1 2018 product launch. Doctors and Public Health Officials from many countries are waiting for the product to be released. The recent agreements with the communications agency Absolu, alongside the participation of Dr. Gauthier, will accelerate these final preparations.”“This new partnership offers ETST a new distribution channel, specialized formulas to market, and remedies to those in need. I personally suffered from asthma as a child and took many pharmaceuticals with side effects to help with the symptoms. I know our current CBD oil has helped many with

Read More Here...